Changes in Biomarkers of Cigarette Smoke Exposure After Switching Either Exclusively or Partly to JUUL ENDS

NCT04107779 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 279

Last updated 2020-07-28

No results posted yet for this study

Summary

A Randomized, Open Label, Parallel Group Study in Adult Smokers to Evaluate Changes in Biomarkers of Cigarette Smoke Exposure After Switching Either Exclusively or Partly to using JUUL Electronic Nicotine Delivery Systems With Two Different Nicotine Concentrations

Conditions

  • Electronic Cigarette Use
  • Cigarette Use, Electronic
  • Tobacco Use
  • Tobacco Smoking

Interventions

OTHER

Switch from UB of Combustible Cigarette to JUUL 5% Virginia Tobacco ENDS

JUUL 5%, ENDS for 6-days in confinement

OTHER

Switch from UB of Combustible Cigarette to JUUL 3% Virginia Tobacco ENDS

JUUL 3%, ENDS for 6-days in confinement

OTHER

Switch from UB of Combustible Cigarette to JUUL 5% Mint ENDS

JUUL 5%, ENDS for 6-days in confinement

OTHER

Switch from UB of Combustible Cigarette to JUUL 3% Mint ENDS

JUUL 3%, ENDS for 6-days in confinement

OTHER

Switch from UB of Combustible Cigarette to JUUL 5% Menthol ENDS

JUUL 5%, ENDS for 6-days in confinement

OTHER

Switch from UB of Combustible Cigarette to JUUL 3% Menthol ENDS

JUUL 3%, ENDS for 6-days in confinement

OTHER

Switch from UB of Combustible Cigarette to JUUL 5% Mango ENDS

JUUL 5%, ENDS for 6-days in confinement

OTHER

Switch from UB of Combustible Cigarette to JUUL 3% Mango ENDS

JUUL 3%, ENDS for 6-days in confinement

OTHER

Switch to Dual-use of JUUL 5% and UB of Combustible Cigarette

Combination use of JUUL 5% (Virginia Tobacco, Mint, Menthol or Mango flavored) and usual brand combustible cigarettes for 6-days in confinement

OTHER

Tobacco/Nicotine Abstention

No smoking for 6-days in confinement.

OTHER

Usual Brand of cigarettes

Continue smoking UB for 6-days in confinement.

Sponsors & Collaborators

  • Juul Labs, Inc.

    lead INDUSTRY

Principal Investigators

  • Mark Rubinstein, MD · Juul Labs, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-09-17
Primary Completion
2020-02-17
Completion
2020-06-24

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04107779 on ClinicalTrials.gov